Portfolio Lab

PACS Group, Inc.

  • Stock
  • Ticker PACS
  • NYSE

Health care · Health care services · USA

$43.67 +1.49%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of PACS Group, Inc. since 04/2024, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

PACSGlobal equities (VT)

$10,000 grew to $36,151. Global equities (VT): $10,273.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −82.0% in 09/2025, measured from the peak in 11/2024. It took 20 months to get back to the old peak.

1-year return
+67.1%
Return p.a. since 04/2024
+27.9%
Volatility p.a.
124.9%
Largest decline
−82.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,2081,2771,3091,3451,3581,4201,4281,499
Operating income7248808695120109100
Net income3728515260817661
Earnings per share0.250.170.310.320.420.500.470.37
Balance sheet
Total assets5,2435,4945,5025,6275,5845,6645,6565,918
Liabilities4,5274,7384,6904,7504,6324,6214,5414,699
Equity7107508078719471,0371,1101,214
Cash158288294356197248164115
Long-term debt251249247246245240239264
Cash flow
Operating cash flow6515053205-3.4236136211
Free cash flow6515053205-3.4236136211

Value it:DCF calculatorMultiples calculator

Annual returns

* partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
3 Nov 2026$0.37
4 Aug 2026$0.47
11 May 2026$0.50
27 Feb 2026$0.42
19 Nov 2025$0.32
12 Aug 2024$0.16

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€6.3bn
Market cap in trading currency
$6.93bn
Enterprise value
$7.09bn
P/E
24.8
P/S
1.21
P/B
5.71
EV/Sales
1.24
EV/EBITDA
–
Earnings yield
4.0%
FCF yield
8.4%

Results (last four quarters)

Revenue
$5.71bn
Gross profit
–
EBITDA
–
Net income
$278m
Earnings per share
$1.76
Revenue per share
$35.94
Revenue growth
+11.5%
Earnings growth
+16.1%

Profitability

Gross margin
–
Operating margin
7.4%
Net margin
4.9%
Return on equity
26.6%
Return on assets
4.7%

Balance sheet and cash flow

Cash
$115m
Cash per share
$0.73
Financial debt
$272m
Debt/equity %
22
Current ratio
0.80
Book value per share
$7.65
Operating cash flow
$580m
Free cash flow
$580m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
159m
Volume
960,862
Avg. volume 3 months
794,257
Relative volume
1.2

Price and technicals

Price
$43.67
1 day
+1.5%
52-week high
$50.26
52-week low
$26.14
Distance to 52-week high
−13.1%
Distance to 52-week low
+67.1%
Distance to 50-day line
−3.9%
Distance to 200-day line
+7.5%
RSI (14)
39
Volatility 1M
52.5%

Performance

1 week
−9.6%
1 month
−8.1%
3 months
−1.3%
6 months
+15.7%
YTD
+13.8%
1 year
+159.5%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has PACS performed since 04/2024?

$10,000 grew to $18,987 by 20 Nov 2026, which is +27.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is PACS?

Volatility was 124.9% per year, measured on monthly returns. The largest decline from a peak was −82.0%, with the low in 09/2025.

How does PACS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +12.4% per year at 12.3% volatility, PACS returned +27.9% at 124.9%. The correlation of monthly returns was 0.05; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

PACS Group, Inc. (PACS): Return and risk | Portfolio Lab